RDFA
INDV icon

Ritter Daniher Financial Advisory’s Indivior Pharmaceuticals INDV Stock Holding History

Ritter Daniher Financial Advisory’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247 Buy
+6
New +$218 ﹤0.01% 580

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $276M AUM 31.26% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Ritter Daniher Financial Advisory's INDV Position: Q2 2026 in Review

Ritter Daniher Financial Advisory opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 6 shares worth $247. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings.

19 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Ritter Daniher Financial Advisory held 6 shares of Indivior Pharmaceuticals worth $247 as of Q2 2026.
  • Indivior Pharmaceuticals was a new Ritter Daniher Financial Advisory position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #580 holding.
  • 19 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.